MARKET

HTGM

HTGM

Htg Molecular Diagnostics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6222
-0.0540
-7.99%
Closed 16:00 05/18 EDT
OPEN
0.6634
PREV CLOSE
0.6762
HIGH
0.6890
LOW
0.6000
VOLUME
115.42K
TURNOVER
23.99K
52 WEEK HIGH
6.98
52 WEEK LOW
0.5500
MARKET CAP
5.34M
P/E (TTM)
-0.2505
1D
5D
1M
3M
1Y
5Y
HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference
TUCSON, Ariz., May 17, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will p...
GlobeNewswire · 1d ago
--HC Wainwright Adjusts HTG Molecular Diagnostics' Price Target to $3 from $4, Keeps Buy Rating
MT Newswires · 2d ago
Recap: HTG Molecular Diagnostics Q1 Earnings
HTG Molecular Diagnostics (NASDAQ:HTGM) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 6d ago
HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Lags Revenue Estimates
HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of -14.08% and 15.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 6d ago
HTG Molecular GAAP EPS of -$0.81, revenue of $1.18M
HTG Molecular press release (NASDAQ:HTGM): Q1 GAAP EPS of -$0.81. Revenue of $1.18M.
Seekingalpha · 6d ago
HTG Molecular Diagnostics Q1 EPS $(0.81) Misses $(0.71) Estimate, Sales $1.20M Miss $2.15M Estimate
HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.71) by 14.08 percent. This is a 1.25 percent decrease over losses of $(0.80) per
Benzinga · 6d ago
HTG Molecular Q1 2022 Earnings Preview
HTG Molecular (NASDAQ:HTGM) is scheduled to announce Q1 earnings results on Thursday, May 12th, after market close. The consensus EPS Estimate is -$0.71 and the consensus Revenue Estimate is $2.15M
Seekingalpha · 05/11 21:25
Earnings Outlook For HTG Molecular Diagnostics
HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that HTG Molecular Diagnostics will report an earnings per sh...
Benzinga · 05/11 16:07
More
No Data
Learn about the latest financial forecast of HTGM. Analyze the recent business situations of Htg Molecular Diagnostics Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average HTGM stock price target is 9.50 with a high estimate of 15.00 and a low estimate of 4.000.
High15.00
Average9.50
Low4.000
Current 0.6222
EPS
Actual
Estimate
-0.82-0.61-0.41-0.20
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 58
Institutional Holdings: 8.49M
% Owned: 111.91%
Shares Outstanding: 8.59M
TypeInstitutionsShares
Increased
2
283
New
4
11.36K
Decreased
8
191.81K
Sold Out
4
21.16K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-1.89%
Healthcare Equipment & Supplies
-2.33%
Key Executives
Non-Executive Chairman/Independent Director
Ann Hanham
President/Chief Executive Officer/Director
John Lubniewski
Chief Financial Officer/Senior Vice President/Treasurer/Secretary
Shaun Mcmeans
Senior Vice President
Stephen Barat
Senior Vice President
Byron Lawson
Director
Christopher Kiritsy
Independent Director
Harry George
Independent Director
Michelle Griffin
Independent Director
Donnie Hardison
Independent Director
James Lafrance
Independent Director
Lee McCracken
No Data
No Data
About HTGM
HTG Molecular Diagnostics, Inc. is a life science company, which is focused on advancing precision medicine through its transcriptome-wide profiling technology. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation.

Webull offers kinds of HTG Molecular Diagnostics Inc stock information, including NASDAQ:HTGM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HTGM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HTGM stock methods without spending real money on the virtual paper trading platform.